K CLL Long Term Follow Up Study
Phase 1
- Conditions
- Chronic lymphocytic leukaemia (CLL)MedDRA version: 20.0Level: LLTClassification code 10009310Term: CLLSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2017-003593-13-GB
- Lead Sponsor
- niversity of Leeds
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
- Will have participated in a CLL clinical trial that is selected for inclusion in the LTFU Study.
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 200
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 600
Exclusion Criteria
- has withdrawn from data collection from either their original trial or as part of LTFU Study.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method